-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G1LfLURa9cy4Kn5aldzEtD1QPpZAiGifIgiNXKBUAlrsacLr7REWz09j3CiTxUMA enaRp6CFUXEi+plgPkz/Iw== 0001193125-07-065748.txt : 20070328 0001193125-07-065748.hdr.sgml : 20070328 20070327173827 ACCESSION NUMBER: 0001193125-07-065748 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20070327 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070328 DATE AS OF CHANGE: 20070327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PSS WORLD MEDICAL INC CENTRAL INDEX KEY: 0000920527 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 592280364 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23832 FILM NUMBER: 07722232 BUSINESS ADDRESS: STREET 1: 4345 SOUTHPOINT BLVD STREET 2: STE 250 CITY: JACKSONVILLE STATE: FL ZIP: 32216 BUSINESS PHONE: 9043323000 MAIL ADDRESS: STREET 1: 4345 SOUTHPOINT BLVD STREET 2: STE 250 CITY: JACKSONVILLE STATE: FL ZIP: 32216 FORMER COMPANY: FORMER CONFORMED NAME: PHYSICIAN SALES & SERVICE INC /FL/ DATE OF NAME CHANGE: 19940318 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 27, 2007

PSS WORLD MEDICAL, INC.

(Exact name of Registrant as specified in its charter)

Commission File Number: 0-23832

 

Florida   59-2280364
(State or other jurisdiction of incorporation or organization)   (IRS Employer Identification Number)
4345 Southpoint Blvd.  
Jacksonville, Florida   32216
(Address of principal executive offices)   (Zip code)
Registrant’s telephone number, including area code   (904) 332-3000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Retirement of Clark A. Johnson from the Board of Directors

At the March 22, 2007 meeting of the Board of Directors, Clark A. Johnson, Chairman of the Board, announced his retirement from the Board. Mr. Johnson, age 75, has served on the Board since September 1999 and as the Chairman of the Board since October 2000. President and Chief Executive Officer of the Company, David A. Smith, will succeed Mr. Johnson as Chairman of Board. Attached as Exhibit 99.1 and incorporated herein by reference is a copy of a press release of PSS World Medical, Inc., dated March 22, 2007, announcing the appointment of David A. Smith and retirement of Clark A. Johnson.

Appointment of Jeffrey C. Crowe to the Board of Directors

The Board of Directors at its March 22, 2007 meeting announced the appointment of Jeffrey C. Crowe, age 60, as a new Director, effective immediately, filling the vacancy created by the retirement of Clark A. Johnson from the Board. Mr. Crowe will be serving as Chairman of the Board’s Strategic Planning Committee and as a member of the Board’s Corporate Governance Committee. Attached as Exhibit 99.2 and incorporated herein by reference is a copy of a press release of PSS World Medical, Inc., dated March 22, 2007, announcing that its Board of Directors has appointed Jeffrey C. Crowe as a new director.

 

Item 9.01. Financial Statements and Exhibits.

 

  (d) Exhibits:

 

Exhibit
Number
  

Description

99.1    Press Release dated March 22, 2007.
99.2    Press Release dated March 22, 2007.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 27, 2007

 

PSS WORLD MEDICAL, INC.
By:   /s/ David M. Bronson
 

Name:   David M. Bronson

Title:     Executive Vice President and Chief               Financial Officer


EXHIBIT INDEX

 

  99.1 Press Release dated March 22, 2007
  99.2 Press Release dated March 22, 2007
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

LOGO

 

Contact: Robert C. Weiner
     Vice President, Investor Relations
     904-332-3287

PSS WORLD MEDICAL APPOINTS DAVID A. SMITH AS

CHAIRMAN OF ITS BOARD OF DIRECTORS

Jacksonville, Florida (March 22, 2007) – PSS World Medical, Inc. (NASDAQ GS:PSSI) announced today that its Board of Directors has unanimously appointed David A. Smith, age 46, to Chairman of the Board, effective immediately. Mr. Smith will continue in his current role as President and Chief Executive Officer of the Company.

Mr. Smith, who has been with PSS World Medical since 1987, was appointed President of the Company in October 2000, named Chief Executive Officer in January 2002, and elected to the Board of Directors in July 1993. He has been the architect and leader of a dramatic turnaround and rebuilding of the business since October 2000, returning a seven-fold stock price increase to investors since that time. PSS World Medical was named one of Fortune magazine’s “Most Admired Companies” for 2007.

Mr. Smith replaces Clark A. Johnson, who is retiring. Mr. Johnson, age 75, has served on the Board of Directors since September 1999 and has served as Chairman of the Board since October 2000. He was previously the Chairman of the Board and Chief Executive Officer of Pier 1 Imports, Inc. (NYSE: PIR) from 1988 to 1998.

Mr. Smith commented, “Our entire organization is grateful to Clark for seven years of leadership and commitment to the Company. I will personally miss his mentoring. Mr. Johnson has enabled our leadership team to sustain significant profitable growth. We are committed to continue our progress while expanding our capabilities and performance for our customers and shareholders.”

PSS World Medical, Inc. is a national distributor of medical products to physicians and elder care providers through its two business units. Since its inception in 1983, PSS has become a leader in the two market segments that it serves with a focused market approach to customer services, a consultative sales force, strategic acquisitions, strong arrangements with product manufacturers and a unique culture of performance.

All statements in this release that are not historical facts, including, but not limited to, statements regarding anticipated growth in revenue, gross and operating margins, and earnings, statements regarding the Company’s current business strategy, the Company’s ability to complete and integrate acquired businesses and generate acceptable rates of return, the Company’s projected sources and uses of cash, and the Company’s plans for future development and operations, are based upon current expectations These statements are forward looking in nature and involve a number of risks and uncertainties. Actual results may differ materially. The Company wishes to caution readers not to place undue reliance on any such forward looking statements, which statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, speak only as of the date made. The Company also wishes to caution readers that it undertakes no duty or is under no obligation to update or revise any forward-looking statements.

 

- END -

EX-99.2 3 dex992.htm PRESS RELEASE Press Release

LOGO

 

Contact:

  

Robert C. Weiner

Vice President, Investor Relations

904-332-3287

PSS WORLD MEDICAL APPOINTS JEFFREY C. CROWE AS NEW DIRECTOR

 


Crowe is a member of the Board of the U.S. Chamber of Commerce

Jacksonville, Florida (March 22, 2007) – PSS World Medical, Inc. (NASDAQ GS:PSSI) announced today that its Board of Directors has appointed Jeffrey C. Crowe, age 60, as a new director, effective immediately, filling the vacancy created by the retirement of Clark A. Johnson from the Board.

David A. Smith, Chairman of the Board, President, and Chief Executive Officer of PSS World Medical, commented, “Mr. Crowe is a great addition to our Board. He brings a wealth of knowledge and experience, especially with the use of technology and logistics, to serve a fragmented market. He is also a proven business leader with a track record of superior shareholder returns.”

Mr. Crowe currently serves as the Chairman of the Board of Landstar System, Inc. (NASDAQ GS: LSTR). From 1991 to 2004, serving as Landstar’s Chairman and Chief Executive Officer (and as President from 1991-2001), Mr. Crowe led revenue growth from $839 million to approximately $1.6 billion, and is one of the founding officers instrumental in taking the company public in 1993. Landstar was named the “Best Managed Company” in the transportation category by Forbes magazine in 2006 and has been named one of “America’s Best Big Companies” by Forbes for eight consecutive years, as well as one of Fortune magazine’s “Most Admired Companies” for 2007.

Mr. Crowe currently serves on the Board of Directors for Silgan Corporation, SunTrust Bank, the U.S. Chamber of Commerce and the National Chamber Foundation. He previously served on the Board of Trustees for United Way of Northeast Florida and was the Chairman of the Board of both the U.S. Chamber of Commerce and the National Defense Transportation Association. He holds a B.A. degree from Drake University.

PSS World Medical, Inc. is a national distributor of medical products to physicians and elder care providers through its two business units. Since its inception in 1983, PSS has become a leader in the two market segments that it serves with a focused market approach to customer services, a consultative sales force, strategic acquisitions, strong arrangements with product manufacturers and a unique culture of performance.

All statements in this release that are not historical facts, including, but not limited to, statements regarding anticipated growth in revenue, gross and operating margins, and earnings, statements regarding the Company’s current business strategy, the Company’s ability to complete and integrate acquired businesses and generate acceptable rates of return, the Company’s projected sources and uses of cash, and the Company’s plans for future development and operations, are based upon current expectations These statements are forward looking in nature and involve a number of risks and uncertainties. Actual results may differ materially. The Company wishes to caution readers not to place undue reliance on any such forward looking statements, which statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, speak only as of the date made. The Company also wishes to caution readers that it undertakes no duty or is under no obligation to update or revise any forward-looking statements.

 

-END-

GRAPHIC 4 g29847img_001.jpg GRAPHIC begin 644 g29847img_001.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`C0**`P$1``(1`0,1`?_$`,D``0`!`P4!`0`````` M```````(!PD*`0(#!`4&"P$!``$%`0$!``````````````$#!`4&!P@""1`` M``8"`@$#`@,%`@8,#P````$"`P0%!@<1"!(A$PDQ%$$B%5%A,A8*<9%"(S,D M%QC!T5)BIF?H M0^7*CHM6-:5\"/\`C/:32>>9]/UIK;,8VTTMK69C7[LK-B:G./S/>RA).K2GDS M(C,RX'S=E&RJW'1,PF5U%M&"JY=UP2__`!W7^J!3FN[X=,K.8W7,]H-&1;)P MW>*RZV5BN.VB"9<-IPW:S(+*LGLFEU/CPILC,_H7`IK(L./,I*C,5;[@]"SF MK4MXVZW>;HHW+]NU.OER790DG[*5)%8_F^(Y=$_4,2R;'\J@FGS1,QN\J;V* MXDE*09H?JYDMI1$I)D9\_4A62IBW(7;?G"2FO\+9](T\ATOR MGZ\DNLLI6XG*[-LNY]0 M9\-LVBT[N7/P7"*\92?!17%_A5M(LMPW#$VS&>5FS4+23IYM^27BV6#M*L=X M?G3N%[.W%=YET_\`C#;MI36*Z=UU>SJ':'9F'"E$RMG*L^@M0;>5@2J-7L25(78M]'W6WTSV[7T.!&&Y=9*/QW9I2Q\=M5I"+T=Q/AS)\O MBE7E-2P_YOU;%7\NN+L3>D(ND[E'XOCRM<:4KX5XF1[J;3NIM!:^Q[5FEL$Q M/6.!XQ".'CV*XE4,4]-"-222]*7%BI:.;83'D^Y)E/*7*E.7 ME[AE3S*EXJ=NZW[*2C<27]Q^YE%+W9?>#"/\YG]9-:;AK$LN*?< MT[O<\;R9)MH6LU1\3VYA&/4[SBS)*4(3D//U/UY))4W*4%\JD_9_QH:SD;IU MU@S;GM.)FX]:UQLQPN4\?X>38M0;\52^EX%)(/RF=;J#*(>"=@ZK;_4K,I:T MQV*SL9@-IB6.SIA.H94U2[(H9&2:^N6/-?*7VK(F%)]?(A:_7V(M*[S0$]_BC+U0YRDN/H+N<(7 ME22C*'V&[9&#L'4>'&[E6L/<<"<:QUD[1N,O\`K;??GC.O@^6#].J] MD%IH0QS?2?S-='8LK)=!=@D=U]3T;1SI.`[-H6[?9C-;&X-V(Q6V$YW(;SP9 M]>:?(/NE\'X0S/T.V=K=;'QV;GKP_JS2YOO5$SGNZ[#^8+MTI9?2NYVNI]BM M_$\?+A_Y7*J549JD[CIP2GS-\(5/KNK'SW:4V%?-ZX[48?:=9=B,6/Z',N+! M^=;ZW3 M%?>OVE;H?\SW2V][@]AZTQ[NQ=00ERR5[F]#F3:HYR49V9)Z-78J*>CN%^NG MR"COJBOOZ2XKKJCMXK-A4W-5-CV57:0)3:7HLVMGPUO19T.0THE-N-*4A9'Z M&8RK:=&N!Z:M2A>MJ]8DKEF234HNL6GJG%K1IK@TVGX'J-/M/&HFUDHT\>1< M&1D1\D1\&1>AF1_W!X5\#[JJT\3F```````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````!3'=&X=?=?]4Y]NG:N01L7UYK3&;++,KNY/"BB M5=:T:U-1F?)*I=C/?4B/$CHY#AQY\J[-1BO:W^ MKS^\HY&1:Q;$\F^^6S!5;]W[?(PJ.M^!;9_J'?D$R+>V_8EOC/2_0$J''1K9 MJSLFZN#CTF2],Q/357+CO$TO.L[:C(M,TM8RV72A()AI3:%P4H]";MD8?:;I M6&U;5)2ZKS5_$NZ5C3YFO*,'I;7B_BE74YCA6KW6N[/-S$X[58=%&NG]GWS_ M`'WY:)K0SA*[%Z:DQR#B>.1&L9HZBGAT-'!H(\2NC4536Q6X57!IXC<=4*'& MJXC*&V&R:-M"$$7B9>@\ZRG.=R5V;FK45RP225 M/!+@D4ARC4^QI#3[^%=A,^QBQ6ZRY%;O,5UAFU%&]ILD&PJNF8=4W3T60HC4 MX2;1ITU'^1Q!$1"*R_=57^GM1B\O`W*ZU+"S[UBCKRNW9NP?L?-;]1+SY;D7 M[2,.P-P]\.O;;U]D&E=<=LM;5R5O6LS0U MP3ZC,-9 MY=7N8MLG#7X[ZHKY7V*3G5R4Q42$>'W,9Z?R5+(MMJ[8FG"_:DM'"Y:E249)^^+\&R16?ZT MP#:V+6&$['Q#&\YQ&U96S8X[E%-77E3*;<0IOE<.PCR&FW4)6?@ZWX.H/U2H MC]15G;MW(N%R,7!^#6ALNX[=@;QASV_=K%K*P+L:3MW81N0DO;&::?L\N*HS M')[._'MV-^/:UR+M%\96PLRK,`J%R45#='7$B993J;'IRWV,[Q MV,P3BY$*0G];A1TFJ)+<(B0WB;N'>P/XVU44*UE;;K'[/%?8U^P\I=9]KNM> MU;O=:=D\W(CM\)2NY&UW&[EIQ2YI>A"5:PXIQ^>,6W";:2+BGQK?*+K7OACT MO&9E=%UWOK%ZPK/)]>'+5)JKVG:6S&=R_7T^2Y]W9427WFBE17^9M>X\@G/< M:6V^NYP=QMYJY-%D1IS*OXKS7@=2[0=Z=@[K8$H6U])U)CVT[^*Z:<$[EF2^ M>US:5IS1?PR\&[K*T)=3P?!D9&7T(R]?[2,AD$Z':$]:K]/M+5/R+?%EI_NU MB-IDM/$J]?\`8NJKW#Q+9L6,B'&R!]DTN1\J;=MJSE16M?"%Y? M]6V^#4JR7%/BGC8=->]6[OC9VWEG5GL]CV0WVBD6D_"=GZENG79]AKL[/E$O M,M:.$^EE^NEPY12'8D=TH=Q"<)^.IN0:'%83!RI[=>E:S7+TO+BXOV>QKP7V M'CSMOW9ZI[(]3W.WO<2W?GTS%^G=M5=R>*Y.BN695I*U)-2<(ODY7_#I*M9-+<;)1J0APVU$DS+A7B?'T%VU0ZLFG[SFY(_IZB"0```` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````,,7^IY[I6UQE> MKN@6O+!Y^+%;I]L;LK*M;JI5WD%K*>C:>P&8AMM'NM-H)ZY=C$M1.OR*Y2B( MVRY[YV8Z=LJ5_JO-25N#].TWPT7\6?N2^!>ULYAU]NLU*WLUB6E.>?M;:Y(^ M_P#>^XR./C(Z/0,9AMRR8212+S:^8-Q[G,I,IY)$2(_WD?'X?O(?/!E31\>!C[_+GTQNL&,_D>ZF2+#7/8?3;S&3[ M-=Q,W(C.=X:P;,:UR>PK8ZVHMA;T,%LBMV5H4U'UKM;5W(=I465C17QJZJKG<(JKK7F@F MG6D47+?CZ[:57=+K3A6ZX\6'4Y-)*7C&Q<<@N*5%QW/L=-AF]A0DN*6Z55/1 M(9GP36:E_93&B49J(S&1Q\FWEV(WK?!_?[3K_;+KC#[C=&8?5F*HPO7K:A?M MIU5J];TG!>-*ZJNO*XM\2;+K9.H4@_HKCGU,OH9'P?'X'P*C2:H^!OM6M5Q1 MA/\`RBZ/RGXV>^6"]ENO7_-'&]@V;NU<*8JT*B4E%F=38L-;.P%R(VHFUXSD M#5FV\J'Q[/V%LZPA/BR7CK&X0EMV7#)QJ)S;T]VK7N?Z]3\ZN^6Q979;NM@] MQ^EN:QMF===[DAP=^#3R,>7!*S>C)3DJ<9-)41E^]>=PT/8'2FKMUXSPBDV= MA%%E\:+YDXJN?M8B'+&G=61%Y2*6S2]$<_'S9/G@QLMN[&]:C=CPE%27N:J> M^^G-\P^IM@P^H=O:>%F8T+L:>'/%-Q?MB_AE[4RK;\YB-Y*?4EIIM+BWGG%I M;:8;;(S-UU:N$-M^G\1F1%^(J\KI4S=*+F?RZZ^"IQJ_`Q#?Z@+(.HFPB M3W"\?!A!#7]ZM6%RW8-?5)I->+C[?+]$>"/S-)-TNRA6,?2N4Y8W&F^>5*TH4X^`?76.[>[4V>PL\S:UL=*!2X@K('S;KXR4-',NC?/C@R7\;3"+ON4ZOEB MDO8FS!_E'P+74O5E[>M[R[U_<-CV^-K"LSE7EMW7<4VO^2W5Q4?#U:^!D\]Q MM=9],U-D6U-'7KF*]@M2TEAF>O[EAGWZW+(V/,2+FXU9G5.1?;Y-A6<5D9Z$ M;#I&Y!FNM3(BV9+27!L%YSE;:MM*2UUX:>'GK^'$]Q]:8F\SV.]N73=Q6^I, M.W*[CM_)=E!A2&E*(E^1%1QPE5RVGI[+>NM'X'`C*-Q))2CDU<>H]<[ICOI/M=5^?J7J*;37_/)LXIB M7/YWU9"]=7-:GDYMQIH MTRA4[3?;##&__P`2]I&\JALMK1#QGLAK6AS=GQY(VFG\[UM.U;E_*"+P)Z0B MQ=\?59N+Y4=-PNKY)IKVK\-//S9@KVT]4XJ4MGW2,TJ4AF6(W51>'J6'CW*O M^M)W&O:4]RC+.]]9CV35&R.LG7#;V*6%-85=V[@'8G(<,3.QV?`E1;[[W'=I MZQ?K$1C@/J)UM=J:?;2L_)7*4CY4[RC2[&+CXM?L3\:>TQ.3G]?VH2Q]QVG; M,W#G"4;DK.;*W\#5)5M9&.HT:=''U6J5JRQ!\&N\MP:GP[LQ3ZTZS[9W]@$W M8V*S81ZWR+6<$\/NRJ+J&_%M#V#F.)-33ML>AUII<@$^E)QN7/`G&_+"[.[T M;%QVX.=IW*Q7,HT5/:SRG^6#J;?-GVG>\;:=ES]SV9[C&5MV+F+#TY2C+FC+ MUK]E2;485<.9:*M*HOHSNY?9UJ')=;ZZ))D$7^+:D3 MV-K6+T-E:OXG$L/*27^`?T&75S(KK9?_`.R#_!M'J"77G5?*^3I#>N;PK?VY M+[6LQO[DRQ9\W^Y=_P"T-*:39WCT^D]=JUG9DZSPK);S=^O]A9+825898L7V M-3<4PZ,N14MJ3*COKD+D*:0J.VDR\UEQB]UO2G"-JY:<&Y?#)N+=:-M+E;I5 M>-3RS^:7J#J;>>D\#%WSI^]M5A;BI6;UW+Q;SDU:FYP].S.8XO9Y9M"2T>93SN5,19-->8^ MU5P[Q^<5>HB:<,D&ES@O!1,"&Y2Q8.WC:O7;5V]ERAZTZODE%V:1FY*&J;23K2E9M+^(#:6Y'8\CN9\ M@79+>$`W7WYV"XA/8UQ@[JI9*.1&3`3.NXB89J,B)+,.-P@O%))+T*\>WRN) M_4WKLXOC%/EC]E-:>]G4/]C=XWWE?<'JO>=SMU^*U9<<2P_?;ASJC\>51=-* MHY.X?13IMU+^//M@K6.F<+Q6<>G;2(SF=M%D9#FLNW5-K6G'X9CN,1U.F7DCQYXH9.'BXVWW968*,DEKQEK[>)'<#MST!T/VFZ@>P[=C8 MUR6V74[M'.]*5*13NW'.YK.4?A4E&KTBBQY_3\E>'WY6JL]S]*1I+8ZLH\"0 M:"K#F8LF`;GG^;_XZ<7Q\?S<_NY%GM7.\VBKR>FZ_>J?M/)WY.OJ?]S\EVD_ MIUM5WG\O]6S2OV_M,D/Y/?D'U7TZT?E5%^N5MUOC/\4N*C6NN6GC=LD'=0Y- M*K-LE8;0LJC$Z`I2Y/G)-H[!QGV(_FHUJ;S&;EPQ+3;HYO1+]ON7B>U.\W=7 M8^VO2N3=OW(7.HAR4K4DXN%N5N M$+;H]5ZB@II-)\LHU1?"&1/1@``````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````00^3[:+FFOCW[B;!CO?;SJKK_L2LJGR<]I;5UEM,YAE*XVY MXJ-+R;;(6?#T]5\>I?4MAZ2P8[EU/@84OEGE6Z^Z,JO\$S#]094L/9,K)CQC M::^V7PK\68'/P,H2U\J_4]LN$H;D;2;3^!<(TML!*2+^X>H>[$G/H/.DN+=K M_P#K$Y-T@E_]AQU_:_\`8S]*]CGVRY].#/\`\_/^R/'GZ?@=Q2HD<,YIQ^,] M':>7'<>9<;0^VE!N,J4GQ2ZW[B'6O<:,R4DE)4DS+U(RY'TDGQ)UHZ+ M3;13WJ?Z;&+A!_,YPMQYFI/W:FI[CO&][+<<\G!NYVV5_P!3$2E>AP_U,634 MYJM:.Q*Y)_\`;2/2U5WEZL;>G*HL3WC@I98PZVS.P?*9YZ_SZME+-*5P;'!L MZ1CV3QIC#BR0MO[92B67'J8A7L>34827._!M5^[C[>!\[7UUTCO5^6+M^X8L MLZ#2E8DW9OQJJTE9O?XG-N^'<*?3NROHWIR+R^O-YC]/CX]MUNPA=3C._)?NQC'Y&Z+F^ M)OEC)J0GQD=.F^E'5O%M673\65L6_FR\^VE+AR4OP_YUOHE=&=IJ]\FFER:[ M%ZBNBU[3I^CJV%NER3@KX&++"Q8VGK+B_+4V;M!V]L]M>A\?IQR4]QE*5[)D MO&_.G,HTI\,4E%7KZG]/Q%ZI/QX M'3N6.J6DJ/S\O*IA5?+=O:\[\=Y->]8-`(5FM1K2V=U;BSE0M$VLR/:&16;/ M^D#(F'X;CK+M#C<>O8B.RC/P:9K);Y'[1^1ZSN.1]9E*Q9;?(Z42_>?%^Y+Q MT7$_.O\`,+ON3W8[HX/;7I3^/9Q&["<'6#RKCA*]-R3:Y+-N,:R_=:N)\=,N MCK-I2AZX:(U7HO&I#7^.EM@Q.ENG,+IS"UQL+&MVDZ4YG"*4I/VRE63] MY5#)\TQ'"X#MGEV58WBM\QYQNNP? M%8)29OZ-C-_EBZW`:M5C8N?=RICI64@U1XZ6F4FV2EX_"GFQ4XXENMV6G,]$ MEXT[7EXW;C990W7F3$Y`_BK7)349UG8M3KS*3.U%90PP@FV6R\6V MTD24-H+T2VVA))2AM"?1*2(B21$1>@RAZ>2452*HCG`D```````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````+)_]0KDRL<^*G?C"6Y*SRG(],XHI M<:2<;V6[';^%RWE2?$N9,-UJN-IQKZ+)SUY(C(^A]JK,;W7>"Y:Q@[DJ>=+< MJ?B:MUG<4.GK\6J\[C'_`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`#2^%*K]12BZZ0YM"5N@?@Q[ ME:)LHV?ZQ[H8!J78MGCGZ-;S<;J";5.BL0G MWTI^I(/Q%6WLU^S+UK-YQOM:M1KK[V_V:FV]'?E@ZYZ,R7NFT=46\+?+UIQO M2AC1NRBYM2DH7+DJ^&LDHN7L)>3OB+[6YDA+&T_EB[,7]>:H?E!HJZ[I%O,L M.+4\TIY&S'6/>5[G#;AQU<&?YDK+A(K+`SKC23]JC]Y:*[X=:/CSZ<,6F*6^WMZ=Q>TL_VH$#`[?8] M?$QS#9[B6F6;#9=AC=(Y=,/MEX'&I&IWZG*X2DR8:,GDV659P,*EJ[.=R_\`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`R.:\TO%T7]U4C]M# M3[_:'IS=+\/+GLN/.$7)FKU,74%& MU%6[:Y8+@E]^GZS=L>[TKTUB1PL+Z'!POW;=OT[<7IK2$:5>FNC;*6YMW81] MLXWHOK;V;["V:VB.(>,:KN-9XVC#;AUOZ5M+8=MW32OQ< M*KEQ?;,C+ETN>;&Y#T7Z_>:/N&S=YNMG]/EY>+TKL5SYH M8[^JSW%\:W_@M6J\/X4JQ=:\Q7?J7\4W4SJ1:Q,RQS$)NQMJMFM]_:NUYK.7 M92Q/>4IZ3.H8SL9BCQN4_(5RJ1%C)FJ+T7(7RHSK8N#8QHZ?%=?&3U;?F_?[ M#-=$=E^@^A;[W';L:65OLI.4LS+DKV0Y.M91E11A)MZRA&+?C4N6$E)?`NZLZQXU\3<`````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````VFM!'XFI)'QY<&9$?'/'/]G(FC?`FC-I.MF9$3B#-7T_,7 MKQ^S]H48::=&FF=9^QKXOA]U.AQO<4I+?W$EEGS4E1)4E'N+3Y&E2B(^/H9B M/9XGRVH_-H,P6G$&9JFU#$"Y:;2HB_S.:YQR:C'GOO?L"Y ML?JFPM72S>?D_P#IR?DFO@]KIXG2>@=R7/=VBY5N7\6->'@G%>WA+3VF:#[B M.?'R29\<\$9&?!>G/'_B'G[QIXHZ8M>!M0^PZCW&WFW$/(B6DS3 MY<\>1$?ISQZ?MX!:\/`C_A^/`\NXIL?R2%^G7]547M>;K;WV-Q`A6D)3[?/M M.G%G,OL&ZWY'XJ\>2Y]!]+FCJJIGS.W"XJ7(QE'VI/\`6=>KQO&*%'A1TU/1 MMJ2VV::B!#JTJ;92I++9E!:CD;;*%&2$_1)&9%P(::^)^!\6K=BQ'EL1A"'E M%**_!(]DT,&D^5>1'R1F;AJ]33P?)F9GR21\UYM2M&K34=4S>TEI!$EOCA)> M)$1\\$7KQ]?PY'TVVZRXD*E*1TBO!<$:FZV1F1N((R/@R-1<\_L^O[@Y6_`A MM+CXFJ'$.$9H4E9$9I,TF1ER7U+DOQ(&FN)(]QODT^:>2YY+R+DN..?[N1#T M57P)2;55PJ:FM*2(U*(B,R(C,R(C,_H1'^\%KP(-ONM<^/N(YXYX\BYX_O#P MKX#A]]`;K1?5Q'K_`+XO]L%KP)H:^XW_`+M'_I%_M@G5T7$AM+B:FM!?522Y M/CU,OK^S^T31CCIXFANMI^KB"_M41?[(ANG$+7@:DI*OX5$?X^A\^@FC0'F@ MSX\D\D?B9)HEQM1F25I,R^I$9<-O$W!6:2E%.\JN,G'2CXT/)OYK,[ M+Q-KV"SCY-_%L7MSE&[.U<=I^GR1JG)>_P`=$0AV_.K_`(\=]=84=%N_N=;^ MK=E;*8H,STW9['J=L8]'Q^1D>.Q(L"QAXD^=`IO(DV\B*A/VL:S^X03\9Q)D M?%M-3P[]OZ.]*[S32E%RYM*TKXO[:FC=1Y9N]C<-RA:OX=[ M)MYL?3=R$:IVU2-7)Q\)5X/B>-A5#UY[;]W>U]#\G?8/8NJMBT6T9V&Z=P63 MF*L`Q>!CD.\O(T:N@9)95-G053$.IBUA0F37!18-R#F>[)6[Y(-8U_,NSW&< MHW87'R1YG%)<%2E*M^TI[5C].=>=SM_P>\V[Y>'NF/N,K.#AN_+%L*USRY'! MUY76,8T556O,N9R5/O/D'UA&ZWYWTDZ>[([$[[B]#[]V_P`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`FY<$R2;12VHY/GXF25H8_3=N3CSK;WZSNTI_IN^I*VKK_K?*J_:1FVW\SFR;_0W7W/^O>O\ M*QK;6:=@+/KON#6>X(U[>1L#SMFIK7X#4691V^,V95$V=9)<;DO,>\3*'6EL MI>961VM[>).U;^EBE=N3Y&IZ.#JEK31O7\31NI?S`[Q=Z4VO=.D,7%M=0Y6] M/;LFQFJ5SZ;(BDI1K:G!N*E)-33U7@G5*56AN[';'%.[&,=(.Y>O]'HRS9F! M7.=X'G/7V]R>QK(C5/#N+%Z#E='D\B995S$N%C(5MI7-2 M,9QUB$["DW!6EU[MUY;WNYNMNQ;_`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`Q'3_`%_^8/.Z:L];W=KV M#.V.[B+(5C'N7K>3*VUS+ES/C95I*DQ1G M57[8VP/]0G$M):YZ[:PRJ=@[V[]^1L M@NYN?Y#6,&Y)508Y1ND<>$ZV\R^EIMAY;$9UE;\E#CWVR*;R\W*DWMR@\:+I MS2J^9KC1*CI[?P*VW]PNXO/,G\*N']=,Y[0XIJ#8.3=[JS4&(7FNY>1RBRS55Q8/XUD6O<:JD6D MG.K&!:.N_P`MNR$MOFB+[I*]MHC6TRI1(/(J=R7J8KGZ,K$(U]249ZPEQJJO15T(`?'9\I.S.V'8#*M6[BUYC MFM\?SW!KC=ENY5R3E\+EHHZ)NE*,DWU2[:[,W3W/[T=?5Y M!G--M/K;7$GU=#$D,.K8X6V4B.XM/H9*,N>/H,+O%6["HVG>5?N/)'YL,%9^ MW]-X]R/-CW-X].2UU4XQ\O8GXES72GQ@](>N.;0]DZIT)C]9G-7+5,H\FO;O M*,ULL?DJ:6U[V/EF-W;1*64EI:DMO1T(?02C\5ER,GBX.%BRW&,VN*_1G M:>F.S?;7H[<([IT]M6/8W&,FX79NY>E;KXV_5G/D?@G%1,A8O/QS+8KT1ZPQ1ZX:228]R MDF5P_+Q84A2#/%9V3@3N3L9,)2OQ;2^#6M*53IK^E3BO=7KKL7U)>SMAZOP< MJ756/ZEFS+Z2\LBA_E$U?G MV7UFQ"V!FV*5F9ZGL,XK->:_AW_V6OH.2G:M-6N.VEDTY.=JH\8W+"!`4V3B M8["FA5LY,,3`MVMPJY72O'\1.)P+#OYV-V9U$Q_9N&]!)^(?: M5\;.F+J/2Y+F,A6/+HX]"5X[)?FKHK2+;/1%K>D3856XAF2LC=0@FW6U"]P.VVGW*WK>>WUK+Q>TEW'BK4+L+D;=R])1/,HRC6E48OWRWZ33H'Y(>V>"1H;<"GL=ES=CXS%8:4S&;QW;$2#L6&U%0 MKT-F++R"1'(T\I\F%$7TX+W/V\W#^:]'X.5)UN6[+LOWVI-/*:X%N@_4C&ZM55#"-55#)$_IW_D?:ZU[ME=2-MY$S7Z0[!7 MS7Y4D8\?9EB[&_Z&[=K]CMW%LO6&9@Y$I134+:ACTG_\QV-W'47) M^AG;C25*S'D]>9EKI:OA,LN+@-8\C%U2,*K[0V6C,X3D&':QE)4@TJ]_\3,B M%[N5N[CRL95N+DK6C2JVUP2]QU'\Q%K*Z#R^F.X?35F4I;1#>CML)P5F254BA3]1ZM*JU_I M>GSUTKZG*^-2PQG_`%8VA%PGKEEO8+$+Y'G,[L<%KDNT>4X3@62HA MU[3Q>W%.7C>325YA-D14K:)^&PU'=<;;<\T%A7@7I.W*^G#U,ER:3UBM&JM< M.''S\:GF'>.A=[M[1L^?U1BY.)G]1];/*N6+3<;N/:N-*-9Q4G:FG*=S5)J* MC6C3IMOC8^2.?J_9.O\GW=C/:5LX&B.VDZIOVE$::LRA/.HC96VOI-OJ;PMUN94S./Z]RC*8K]"4AJH-]R930I##+Y3JMY/M*, ME>))47)*(6.)F6,2=^%SF;]5\(MFH=J^ZO1O;C+ZCVCJR]?L9V3U+E7;:C8N MW$X/DMI\\(..LH/@W[3S>N_=_1/53Y+/D1V;N"3G%?BNX+BC/!'Z+`LBR&;9 M>Y+;R-A,F!!B*?K52*RT8-LGR3RM?@?"DF0FSEV,;\?6&;U)=O6\?.O6/1Y+%VZY?-*E(1ERRI*-%*CKQ6A,KJ2>=]OOD9 MSOY$;+5V>:?Z_:ST8O4VK'=E4;N+Y#LM;OW+UAD)U$A"S350X$Z?(<4TIYEH MW(K277%D\2+G'KD;E/-MI_3^FHIM--NM71/7CYT.C]#V=RZ[[O9/=6]B9>#T MI@[7]%BRR+;M7;\N=RE>5MZ^FHSN*KXODIJIBUQ^5+P/D M?B37L_N=VMTQGFVZJ0WB_P`>/7.MUAC$&VBS'TSQ95N<<#%ZMQK\'\2BXW+N1"27+\7^F[ M\3!LFB/[J$$OVC2GRYJSN8'I7(6(S61Z3U:EPK]JXG2O-9$*UA0CF7I,LL/43-A+:]YR&4B0ZG\K39J,S16QK?M\%[39>@>^?2^T=L<#IS:+&X;CU?B;="S]+9QKKK?IR14 MYN*A&',US-2;IP3X$+:GJGG^@-B_#;I[;D";29KF^P]NY9FU/%OE3@: M'C]![MT?O?;C8MWA)9\\S-G?C&K5KZFY;DH*:JN:-JE772:;K15)N]`.U.'? M%M1;`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`````````````````````````````````````````` M``````````````````````````````````````````````.C*K8$Y25S(C$E M2"\4&\@G/`N3/\A*Y))\G]2]0_8ZAZKE?R^7M\_8_;Q.XI"5EPHB,OKP?T_N M"K0\:^*=3QY.-X_-G1+2;254VSKU+57V4R!%EV$!2T^*SA39#3DF(:D^A^VI M/IZ?0&E+B4Y6;4IJY.,7$)27H1%QP(6A*23J MM-*:::+PT.'].@>\4C[2/]P2B44GVD_<^1)\"5]QQ[QGX>G\7T]`>I"23YDE MS>=-3<]`AR5(5(C-/*;4:VU.)):FUF9'YMFKDT+Y27J7!D(HG'E?`G2M6DW5 M/@N*X&XXD[R^PZB:2H21DF MMA<*,S5S';/DU'Y*,S-)F9FKU/\`:8G2M:*K]A\!UH]9`BI6F-%980OQ\D-) M\&S\?I^1)D@C_;P7K^(CPY?`^(PC'2*HGX>'EPX>'V^(:K(#*S<9B,LK5Y&H MVD>WY&HC)2E$CQ)2C(_J?J"T7*N#/J/PNL=-:Z:*OG3@;%5%8KDE08QI-PWE M(-M)H<>5QRZXW_`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``````````````````````````````````````````````````````````` M```````````````````````````````````````+%?\`41=?D[H^-K8.7PHZ MI&1=>^6L7_`'DD:GUIA_5;%-JP-[VV[M>YQ5S`NQ M:DG^[Y2B^*:=&F7.+F9.%D1R\>;5Z#JOL\'YZ'Z9/QK?(5J[Y$NOE1M##5PJ M'85`B!1[JU?]ZV]::ZSAYAQQUM#:GERI6(9&J.]*HIZBXEPR-*_&0R^VWXQZ MJZ8S>DMTEMN7K8XVKG[LX?NT]J5$UX/\>Y[%O6-OF%]1;I')C_J0_JR_H?S+ MV,N'C7#,@``````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````?#;-U]CNV==9UJ_+XI3L4V)B.183DL,^".319143*2T:0 M9DHDNJA35^"N#\5\'^`JX]^[BY%O*L.EZUO?X?Z#?_W5GII_VANT'_'M2?\`5>(_WJZF_P#C MX/\`O\`^'_*/^ZL]-/^T-V@_P"/:D_ZKP_WJZF_^/@_W)_Y MQ_M[M?\`WK_^'_*2TZ6_!9J;HANZEW?H[M'V;CV,5E57EF&W4_6,G"-CXNZH MW'L9S2HAZ[@N3H;WK;]UQ,)PA+FA M*,)*<)><7SO[4]'Y&4VKI/'V?*65AW[ZE2C58TDO*6G`OECGIM8````````` M```````````````````````````````````````````````````````````` M```````````````!T6K2M?BNSF;&"]"8]TGYC4N.Y%9-CU?]V0APV6_9+^/D MR\?Q`':9>9D--OQW6WV'D)=9>96EUIUM9$I#C;B#4A:%I/DC(S(R`'(````# M@DRHT)AR5,D,1(S1$;LB2ZVPPT1J))&XZZI#:"-2B(N3+U,`>;'R+'Y;S<:) M>TTJ0\KQ:CQ[2$\\ZK@U>+;3;ZEK5XD9\$1^A`#V0`````!U4383DIZ"W+BK MFQD(=D0T2&E2F&W2(VW'HZ5FZTAPC_*:B(C_```'`BXJ'(;UBW:5RZ^.I2'Y MR)T94-A:#22TO24NFRVI)K+DE*(RY+]H`[S;B'4(=:6AQMQ"7&W&U$M#B%D2 MD+0M)FE2%)/DC+T,@!O````!P29,:$P[*F2&(D5A!N/R9+K;##+:?XG'7G5( M;;0G\3,R(@!PU]E76T9$VKGPK*&X:DHEU\IB9&6I)\*)#\=QQI1I/Z\'Z`#N M@``````````````````````/%9R3'I#R(\>^I7WW%>#;#-I!=>6OZ>"&D/J6 MI7/X$7(`]H``````=>5+BP6%RILF/#C->/N2)3S<=AOR42$^;KJD-H\EJ(BY M/U,^`!Y\;(-9PGWW#2DUF3;33ZG%F24F9\$?H0`]@` M`````=94R&F6B`J7&3.<95(;AJ?:*6Y'2KP4^B.:O>4RE7H:B+Q(_P`0!V0` M````!M6M#:%N.+2VVVE2UK6HDH0A)&I2UJ49)2E*2Y,S]"(`>&G*<86I*49' M0K4M24H2FWKU*6I9D24I(I!FI2C/@B+ZF`/>``````&BE)0E2E*)*4D:E*49 M$E*2+DU*,^"(B(O4P!UXDR'/81*@RHTV,X:B1(B/M26%FA1I42'F5+;4:5$9 M'P?H9`#L@`````#S;*YIZ9#+EQ:UM4W(<]EARRG18*'W?0_:95*=:2XYP?\` M"7)@#T4J2M*5H4E2%))25),E)4E1I@#PBRK%U&1)R2A,U&1)(KBO,S,SX(B(I'J9F8` M]X``````````````````````!C@:PSS*--Z2VU"R5QR3IOLE3;VQG'I327'& M/EX\9?CI^7C^/C]>`!0'K7IF M'79AK'(Y/1C&=OG7O;4W]8_P!R M9KY\#`G0NA@0`````6F.V&Q_(-3:]SGI1,F27KK=&8=9+FB8>3X+?B[#BURMC M(;3P7DW4WN-MQEF1>J2Y4?(@DR&*ZOB5-?`JX#26(-;#BU\-A)$268D-A$>. MTDB(B)+;+9$7]@D@[@````(+=Z-?W&RL:U=CM!;X9964?8D:\_T-YMEY8=7[ MMAU<%[[K%(TQ$N+(F2X7W*7R:(_;X4:E*2HDMK#F3["S+ M*<+PSLU;YG&QO&*+*I60S&ZARVD1'GIM(G'O;-"52FF69/L*\5*22N!)D<:Z MI+K&]?X1CN27/\Q9#18ECM/>7WFXY^LVU;41(=A9DZ\1/.E-E,J<\U_G7Y]E]&<8SB'.54R96YY6UZ*KG2V&2[E M2\36I-@V[2(9Y3%/_&/?;%X_QD!.A?/`@`````A=WWVY_HIZZY.U`LF*S)=B MO1];X[+?>)E$%S)4NLW=NZK_`"C<>HQUN4ZIQ)#YY79]A-*JKV+K'(X,CW&IM=:UM5#S:I(W&HZTR*G(%MN>VE''#[BRY+D MP)+JH$`````%I_LKJ.WS+L?DF:,ZXPCMECE9@-#06VFG]EQL;SC4KZO>D_K% M53.S"8;/)6UF^TZM!/K6I7B2?%*U"2471RZPVTT%4UF$3=@NUF(Y%DN)SJ;9 M\F!,R[$+BMG^_/Q&3,K8T:))@4IS4IB*)/*8ZDH5XFDT)$,E\````#Y?-_\` MZ+R__HO?_P#RF6`7$LB=4--1,IU1JJ[E=&,9V7$L)/E*V_-VQ14CK7K_,9R*QP>TR&SRHI7$ MDPL>R';4ZUQ:6S":-B/6V=*=:RQ+JD,\)]CE*>$D1<$0BB)J2O$D`````%`] MX];M;=A',$ZT@VE*\" MX60`TS7K;K7/MR:]WI?M7)YOK6,46A3#GL,4TI#3T^3""S+GDB(@!7T``````49W5H?`=\T=139LU<196.7#.08KD^,6KU#E>+7 M3*?!-C17,=+BXCRV_P`JTJ0MM?"3-/DA"D@?-Z>ZRX'IO),AS>!=9YG6?9/7 MQJ>USG9>52,LR55+$=0^S3Q9;D>''B5_OM(6I*&O)1MIY49)(B`D4``````` M``````````````-%%Y$:3^AD9'Q^\N`!&RGZI:EJ=%7'7=V+=76O+MV\DR2N M["/*O&)MY:.W2Y\&R8@16XTRMLW"=B+)DS:4A//F7)&!6?!,1C8#AV-X5"MK MV]@XQ51:6#:9+-9L;V3!@H]F$FQGL183/]M*?BS6FO*5`02^6 ME/ M0\QV'FS4RV?MU6NRLJ?R^\87(BPXIP8ME(CQELUC10R6AGQ,DN.+5S^8`5-` M```!Y-]31,CHKK'K!3R8%[4V---5&6EJ0F):0WH,E4=Q2'$MO$R^KP4:5$2N M#X/Z`"&^.=$\'Q&NJ:;&MT]FZ6DI":164=9N"5`IXC+3YR3C,UL2F8BM1GGE M*-:$)2E1K5^TQ%$R:DWA)`````!1S/-&X5LG/M;;!RY5O93=5O7,S&,?5+BG MBCEE=Q40Y%I;U+L%URPGQ6FD?;J-Y"&E((_$_7D#K7&@->VFT<`V_$C3L;S# M7<.\K*Q>,+@5-9<560,&Q.J\D@)KG2LX:/)2VB2II;;BC42OIP!6P``````1 M?VCU-U[L[.5[+:R79>M<\ETS./W63:JS.1A]AD=-&(DQ8-\2(DUB
-----END PRIVACY-ENHANCED MESSAGE-----